Gary S. Stetz insider trades: Hepion Pharmaceuticals (HEPA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | HEPA | ↑ Buy | 2,000,000 | $0.05 | $100K | Direct | Aug 12, 2026 (9d) |
| May 26, 2026 | CNTN | ↓ Sell | 100,351 | $3.43 | $344K | Direct | May 27, 2026 (1d) |
| Mar 14, 2018 | BCBP | ↑ Buy | 500 | $15.80 | $8K | Direct | Mar 14, 2018 (0d) |
| Oct 25, 2017 | BCBP | ↑ Buy | 1,500 | $14.60 | $22K | Direct | Oct 25, 2017 (0d) |
| Oct 25, 2017 | BCBP | ↑ Buy | 250 | $14.50 | $4K | Pension Plan | Oct 25, 2017 (0d) |
| Sep 12, 2017 | BCBP | ↑ Buy | 10,000 | $12.25 | $123K | Direct | Sep 14, 2017 (2d) |
| Jun 20, 2017 | BCBP | ↑ Buy | 250 | $15.50 | $4K | Pension Plan | Jun 20, 2017 (0d) |
| Dec 15, 2016 | BCBP | ↑ Buy | 725 | $12.94 | $9K | Pension Plan | Dec 19, 2016 (4d) |
| Feb 26, 2016 | BCBP | ↑ Buy | 800 | $9.92 | $8K | Pension Plan | Feb 29, 2016 (3d) |
| Aug 25, 2014 | BCBP | ↑ Buy | 1,000 | $13.04 | $13K | Pension Plan | Aug 26, 2014 (1d) |
| May 8, 2014 | BCBP | ↑ Buy | 1,000 | $13.20 | $13K | Son | May 9, 2014 (1d) |
| Apr 24, 2014 | BCBP | ↑ Buy | 400 | $13.18 | $5K | Pension Plan | Apr 25, 2014 (1d) |
| Feb 3, 2014 | BCBP | ↑ Buy | 400 | $13.16 | $5K | Pension Plan | Feb 5, 2014 (2d) |
| Dec 17, 2013 | BCBP | ↑ Buy | 835 | $12.00 | $10K | Son | Jan 8, 2014 (22d) |
| Dec 10, 2013 | BCBP | ↑ Buy | 1,000 | $13.75 | $14K | Pension Plan | Dec 11, 2013 (1d) |
| Jun 12, 2013 | BCBP | ↑ Buy | 1,000 | $10.22 | $10K | Pension Plan | Jun 13, 2013 (1d) |
| May 20, 2013 | BCBP | ↑ Buy | 1,000 | $10.47 | $10K | Pension Plan | May 20, 2013 (0d) |
| Dec 17, 2012 | BCBP | ↑ Buy | 1,000 | $8.89 | $9K | Pension Plan | Dec 17, 2012 (0d) |
| Nov 12, 2012 | BCBP | ↑ Buy | 1,000 | $9.90 | $10K | Pension Plan | Nov 13, 2012 (1d) |
| Aug 28, 2012 | BCBP | ↑ Buy | 1,000 | $10.34 | $10K | Pension Plan | Aug 29, 2012 (1d) |
| May 18, 2012 | BCBP | ↑ Buy | 1,191 | $10.62 | $13K | Pension Plan | May 21, 2012 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HEPA insiders
Open-market trades in the last 12 months
About Gary S. Stetz's insider trades
Gary S. Stetz is Chief Financial Officer at Hepion Pharmaceuticals (HEPA). Since May 18, 2012, Gary has reported 20 open-market purchases worth $400K and 1 sale worth $344K on SEC Form 4. In the last 12 months: 1 buy ($100K) and 1 sale ($344K).
Their filings also include grants and awards (8 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HEPA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.